Clinical Trial Update: Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of vesatolimod for chronic hepatitis B in virally-suppressed participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Vesatolimod (vesatolimod)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2020-09-02